Study summary
Low-dose isotretinoin cleared most bumps, but rosacea often came back
70%fewer bumps and pimples at 16 weeks
What was tested
A pooled look at studies of low-dose isotretinoin, an acne pill, for hard-to-treat rosacea.
What they found
- Bumps and pimples fell by about 70% and redness by about 47%.
- About 35% relapsed within roughly 5.5 months of stopping.
What it means
A strong option for stubborn bumps and pimples, but many people need ongoing treatment.
Last reviewed 2026-11-14 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.